---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-012280"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T06:04:41.554743+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Q1 revenue down 83% to $891K; operating loss widens to $3.8M

## Summary
- Revenue $891K vs $5.3M YoY, down 83% due to COVID-19 testing decline (CUNY contract ended) and lower cotton DNA tagging revenue.
- Operating loss $3.8M vs $1.2M YoY; Adjusted EBITDA negative $3.2M vs negative $1.1M.
- Cash $3.4M at Dec 31 vs $7.2M at Sep 30; post-quarter closed $3.44M direct offering with warrants.
- Company projects initial GMP facility capacity enabling up to $15M annual Linea IVT revenue, expected online H1 2024.
- Clinical-stage mRNA customer evaluation: Linea IVT templates met/exceeded all metrics, fastest manufacturing speed.

## SEC filing metadata
- accession: 0001104659-24-012280
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465924012280/0001104659-24-012280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465924012280/tm245568d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-012280
- JSON: https://secwatch.observer/filing/0001104659-24-012280.json
- Plain text: https://secwatch.observer/filing/0001104659-24-012280.txt

## Key facts
- Earnings Releases
  BNB PLUS CORP. reported the three-month period ended December 31, 2023 results: revenue approximately $891 thousand.
  - Period: the three-month period ended December 31, 2023
  - Revenue: approximately $891 thousand
  - Result: reported results
  source text: Total revenues were approximately $891 thousand for the three-month period December 31, 2023, compared to $5.3 million for the same period in the prior fiscal year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/744452/000110465924012280/0001104659-24-012280-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.